Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Osimertinib as First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC?

By Beacon Medical Interchange FEATURING Jack West

0 views

November 2, 2018

Dr. Jack West reviews the pros and cons of using osimertinib first line vs. "saving" ...
read more ↘ it as a second line therapy, trying to determine the optimal sequence for EGFR-directed therapy in advanced EGFR mutation-positive NSCLC.
↖ read less

Comments 0